Orlistat: Clinical Trials

19 trials of Orlistat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 3 terminated, 3 unknown, 1 not yet recruiting. 19 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 419Completed 12, Terminated 3, Unknown 3, Not yet recruiting 1

Follow Orlistat: new trials by email Literature Review of Orlistat trials Research Report on Orlistat

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.
liraglutide monotherapy, liraglutide combined with orlistat - Overweight and Obese Adults
Phase 4Not yet recruitingThe Fourth Affiliated Hospital of Zhejiang University School of Medicine1202026-05-012026-03-23
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
Liraglutide, Orlistat - Non-alcoholic Fatty Liver Disease, Obesity
Phase 4UnknownAffiliated Hospital of Nantong University1022023-11-012024-07-15
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
Semaglutide, Orlistat, Phentermine/Topiramate - Obesity
Phase 4CompletedNovo Nordisk A/S5002023-01-192026-01-14
Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia
Orlistat, Orlistat placebo - Uric Acid
Phase 4CompletedShanghai 10th People's Hospital722022-08-262023-12-14
EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
Weight Management Program (WMP), Traditional care, Phentermine / Topiramate Extended Release Oral Capsule - Type 2 Diabetes, Obesity
Phase 4TerminatedThe Cleveland Clinic742020-09-012024-09-19
Weight Loss Aid in an Exposed Population
Orlistat, Placebo capsule, Multivitamin - Polybrominated Biphenyl Poisoning
Phase 4CompletedEmory University1002018-09-142026-10-20
Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
Acarbose 100 MG, Exenatide, Orlistat - PCOS, Impaired Glucose Tolerance
Phase 4UnknownRenJi Hospital1602018-01-012017-12-26
Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment
Roux-en-Y Gastric Bypass (RYGB), Incretin analogues, Xenical - Type II Diabetes in Subjects BMI 27 to 32
Phase 4CompletedKhoo Teck Puat Hospital402014-02-012022-06-23
Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
Liraglutide, Orlistat, Liraglutide + Orlistat - Type 2 Diabetes, Gastric Banding
Phase 4TerminatedEast Carolina University12012-06-012018-02-05
A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.
Orlistat - Obesity
Phase 4CompletedAlbany College of Pharmacy and Health Sciences192009-11-012014-04-04
Effect of Orlistat in Body Composition
Orlistat, Placebo - Obesity, Overweight
Phase 4CompletedGlaxoSmithKline1312008-09-012013-03-08
Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons
Xenical + behavioral intervention, Behavioral intervention + placebo - Obesity, Binge Eating
Phase 4CompletedYale University792007-08-012020-04-02
Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus
Xenical, Pegasys, Copegus, Xenicare Program - Fatty Liver, Hepatitis C
Phase 4CompletedBrooke Army Medical Center302005-08-012012-02-14
LOSS- Louisiana Obese Subjects Study
group sessions, sibutramine, orlistat, diethylpropion, Low Calorie Diet, Health One - Obesity
Phase 4TerminatedPennington Biomedical Research Center3902005-07-012016-02-22
The Effect of Xenical on Weight and Risk Factors
Orlistat - Obesity, Heart Diseases
Phase 4CompletedUniversity of British Columbia252005-06-012013-04-01
The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)
Orlistat, Sibutramine, Diet and physical exercise - Obesity, Polycystic Ovaries Syndrome
Phase 4UnknownAristotle University Of Thessaloniki2002004-01-012011-11-21
Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
Orlistat (Xenical), 1400 kcal diet (30% fat) - Fatty Liver, Hepatitis
Phase 4CompletedSt. Louis University502003-10-012007-11-20
Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults
Orlistat - Obesity
Phase 4CompletedHoffmann-La Roche502002-07-012016-04-05
Effectiveness of Brief Counseling for Weight Management
orlistat, Brief cognitive behavioral counseling - 1. Obesity
Phase 4CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2462002-01-012010-03-18

Conditions studied

Obesity (11)  ·  Diabetes Mellitus, Type 2 (2)  ·  Fatty Liver (2)  ·  Insulin Resistance (2)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Overweight (2)  ·  Bulimia (1)  ·  Diabetes Mellitus (1)  ·  Glucose Intolerance (1)  ·  Heart Diseases (1)  ·  Hepatitis (1)  ·  Hepatitis C (1)  ·  Weight Loss (1)

Sponsors

Affiliated Hospital of Nantong University (1)  ·  Albany College of Pharmacy and Health Sciences (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Brooke Army Medical Center (1)  ·  East Carolina University (1)  ·  Emory University (1)  ·  GlaxoSmithKline (1)  ·  Hoffmann-La Roche (1)  ·  Khoo Teck Puat Hospital (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Novo Nordisk A/S (1)  ·  Pennington Biomedical Research Center (1)  ·  RenJi Hospital (1)  ·  Shanghai 10th People's Hospital (1)  ·  St. Louis University (1)

Countries

United States (11)  ·  China (3)  ·  Canada (1)  ·  Greece (1)  ·  Singapore (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Anton Cheng, MBBS (1)  ·  Bartolome Burguera (1)  ·  Brent A Tetri, MD (1)  ·  Carlos M Grilo, PhD (1)  ·  Dimitrios Panidis, PhD (1)  ·  Donna H Ryan, MD (1)  ·  GU Yunjuan, doctor (1)  ·  Jiri Frohlich, MD (1)  ·  John P Foreyt, PhD (1)  ·  Margaret Malone, PhD (1)  ·  Michele Marcus, PhD, MPH (1)  ·  Stephen A Harrison, MD (1)

Results publications

PMID 19053049, PMID 20101009, PMID 21962313, PMID 23376451, PMID 34582624, PMID 35513159, PMID 38468241, PMID 42746240

NIH funding

R01ES025775 (1)